In Maine, Making Cancer DNA Tests Free—And Asking Tough Questions
MAY 31, 2017
But the commercial tests used to decipher cancer’s genetic fingerprints are still an elite tool, often reserved for clinical studies and major cancer centers, and are. Has the era of genetic oncology arrived? Last week, the biomedical world took a notable step in that direction when the FDA said Merck’s drug pembrolizumab (Keytruda), already one of the world’s most successful cancer immunotherapies, could now treat any tumor with a particular genetic fingerprint.